ASH 2020 CLL Roundtable: Treatment Overview & COVID Concerns
View All In Series
Published on December 14, 2020
Experts Share The Latest Developments in CLL Treatment and Patient Care
What are the treatment options and newest developments in treatment research for chronic lymphocytic leukemia (CLL)? How do healthcare disparities affect access to CLL care? What should patients know about CLL and COVID-19?
Patient Power host and patient advocate Michele Nadeem-Baker spoke with three of the world's leading CLL experts on the latest updates on the disease from the American Society of Hematology Annual Meeting & Exposition (ASH 2020). Dr. John Allan, MD, of Weill Cornell Medicine, Dr. Jacqueline Claudia Barrientos, MD, of Northwell Health and Dr. Bill Wierda, MD, of MD Anderson Cancer Center, shared the important research they presented at the conference, as well as information on the future of chemotherapy for CLL, care disparities and how to allay anxieties from COVID-19.
This program is sponsored by AbbVie Inc. and Genentech Inc. and Adaptive Biotechnologies. These organizations have no editorial control. It is produced by Patient Power, and Patient Power is solely responsible for program content.
Recommended Programs:
